CAS: 3900-93-4; 2-Cyclopentyl-2-Phenylacetic Acid

该化合物是一种有机化合物,其特点是其独特的结构,其特点是环戊基组和一个附属于中央乙酸酸协会的联苯组,该化合物一般是白色的,以在有机溶剂中的中溶性而闻名,但因其疏水特性而在水中较不易溶解.环丙基和苯基组的存在有助于其作为热液化合物的潜力,这可能影响其生物活动和在各种化学环境中的互动.酸功能组允许潜在的再活动,包括酯化和盐形成,使其在合成有机化学中有用.此外,2-Cyclobentyl-2-苯乙酸可能具有有趣的药用特性,尽管具体的生物活动取决于进一步的研究和背景.与许多有机酸一样,必须谨慎地处理这一化合物,并遵循适当的安全议定书,以减少与使用该化合物有关的任何风险.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号103-82-2 苯乙酸 | CAS号1556-18-9 碘环戊烷 | CAS号3753-59-1 rac-cyclopentyl... | CAS号930-28-9 氯代环戊烷 | CAS号140-29-4 苯乙腈 | CAS号110480-94-9 rac-(cyclopenty... | CAS号5422-88-8 苯基环戊基酮 | CAS号7037-44-7 Cyclopentyl(phe...

合成工艺路线路线简述

    碳酸甲丙酯 以 水 作为反应溶剂,化学反应生成 α-苯基环戊基乙酸
    参考文献:软药品.3.一类新的抗胆碱能药.
    标题:软药品.3.一类新的抗胆碱能药.
    摘要:设计并合成了一类新的抗毒蕈碱药物.这些化合物是"软"季铵酯,其中只有一个碳原子将酯氧和季头分开.当衍生自受阻的"伞"酸时,该化合物是有效的抗胆碱能药,而当衍生自简单脂肪酸时,这些化合物是胆碱能药.与阿托品相比,更有效的抗胆碱能药具有高达10倍的乙酰胆碱拮抗剂活性,但作用时间却短得多.该化合物水解裂解,同时破坏四级头.该化合物有望作为选择性的局部药物,特别是作为内分泌出汗的抑制剂.
    DOI:10.1021/jm00179A002

    海关参考信息

    专利信息


    专利号:US-6531470-B1
    优先权日:1998-01-23
    标题:Oxazolidinone combinatorial libraries, compositions and methods of preparation
    发明人:GORDEEV MIKHAIL F; LUEHR GARY W; PATEL DINESH V; NI ZHI-JIE; GORDON ERIC
    权利人:UPJOHN CO
    摘要:Oxazolidinones and methods for their synthesis are provided. Also provided are combinatorial libraries comprising oxazolidinones, and methods to prepare the libraries. Further provided are methods of making biologically active oxazolidinones as well as pharmaceutically acceptable compositions comprising the oxazolidinones. The methods of library preparation include the attachment of oxazolidinones to a solid support. The methods of compound preparation in one embodiment involve the reaction of an iminophosphorane with a carbonyl containing polymeric support.

    专利号:US-6562844-B2
    优先权日:1998-01-23
    标 题:Oxazolidinone combinatorial libraries, compositions and methods of preparation
    发明人:GORDEEV MIKHAIL F; LUEHR GARY W; PATEL DINESH V; NI ZHI-JIE; GORDON ERIC
    权利人:UPJOHN CO
    摘要:Oxazolidinones and methods for their synthesis are provided. Also provided are combinatorial libraries comprising oxazolidinones, and methods to prepare the libraries. Further provided are methods of making biologically active oxazolidinones as well as pharmaceutically acceptable compositions comprising the oxazolidinones. The methods of library preparation include the attachment of oxazolidinones to a solid support. The methods of compound preparation in one embodiment involve the reaction of an iminophosphorane with a carbonyl containing polymeric support.

    专利号:US-9217012-B2
    优先权日:2009-04-08
    标题 :Inhibitors of protein tyrosine phosphatases
    发明人:ZHANG ZHONG-YIN; ZHANG SHENG
    权利人:ZHANG ZHONG-YIN; ZHANG SHENG; UNIV INDIANA RES & TECH CORP
    摘要:Disclosed herein are compounds that selectively inhibit members of the PTP family of enzymes. Synthesized compounds demonstrated selective inhibition of TC-PTP. Also provided are methods of using the compounds and formulations containing the compounds. Also described is a fluorescence-tagged combinatorial library synthesis and screening method. And methods of using these compounds to effect enzyme activity both in cells and in vitro as well as method of using these compounds to treat diseases in human and animals.

    专利号:US-7002020-B1
    优先权日:1998-01-23
    标题:Oxazolidinone combinatorial libraries, compositions and methods of preparation
    发明人:GORDEEV MIKHAIL F; LUEHR GARY W; PATEL DINESH V
    权利人:UPJOHN CO
    摘要:Oxazolidinones and methods for their synthesis are provided. Also provided are combinatorial libraries comprising oxazolidinones, and methods to prepare the libraries. Further provided are methods of making biologically active oxazolidinones as well as pharmaceutically acceptable compositions comprising the oxazolidinones. The methods of library preparation include the attachment of oxazolidinones to a solid support. The methods of compound preparation in one embodiment involve the reaction of an iminophosphorane with a carbonyl containing polymeric support.
    上海巍涛化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.witofly.com
    企业联系电话:021-50630626,17717886015👤
    📞上海巍涛化工有限公司 ⚠️参考联系方式
    联系人:销售部
    电话:021-50630626,17717886015
    手机:17717886015
    传真:021-50563898
    邮箱:sales@witofly.com
    通信地址: 上海市松江区沈砖公路5808号14幢5层536A室
    邮编: 200127
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市松江区沈砖公路5808号14幢5层536A室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: B Liebmann, Et Al. Studies On The Metabolic Clearance Of Ciclotropium To Alpha-Phenylciclopentylacetic Acid Using A New Enantiospecific Metabolite Assay. Arzneimittelforschung. 1992 Nov;42(11):1354-8.
    [参考文献]: N Bodor, Et Al. Soft Drugs. 3. A New Class Of Anticholinergic Agents. J Med Chem. 1980 May;23(5):474-80.
    [参考文献]: Radoslaw Laufer, Et Al. Discovery Of Inhibitors Of The Mitotic Kinase Ttk Based On N-(3-(3-Sulfamoylphenyl)-1H-Indazol-5-Yl)-Acetamides And Carboxamides. Bioorg Med Chem. 2014 Sep 1;22(17):4968-97.

    合成参考文献


    摘要:Cunha, J. C.; Dedeiras, B.; Negrão, A. C. R.; Marques, M. M. B., Science of Synthesis: Hypervalent Halogens in Organic Synthesis, (2025) .
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知